Antiviral activity and in vitro mutation development pathways of MK-6186, a novel nonnucleoside reverse transcriptase inhibitor

Item

http://www.wikidata.org/entity/Q36018893

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Antiviral activity and in vitr ...... everse transcriptase inhibitor

@ast

Antiviral activity and in vitr ...... everse transcriptase inhibitor

@en

type

Item

label

Antiviral activity and in vitr ...... everse transcriptase inhibitor

@ast

Antiviral activity and in vitr ...... everse transcriptase inhibitor

@en

prefLabel

Antiviral activity and in vitr ...... everse transcriptase inhibitor

@ast

Antiviral activity and in vitr ...... everse transcriptase inhibitor

@en

P1476

Antiviral activity and in vitr ...... everse transcriptase inhibitor

@en

P2093

Daria J Hazuda

http://www.w3.org/2001/XMLSchema#string

Georgia B McGaughey

http://www.w3.org/2001/XMLSchema#string

Jay A Grobler

http://www.w3.org/2001/XMLSchema#string

Meiqing Lu

http://www.w3.org/2001/XMLSchema#string

Michael D Miller

http://www.w3.org/2001/XMLSchema#string

Ming-Tain Lai

http://www.w3.org/2001/XMLSchema#string

Neville J Anthony

http://www.w3.org/2001/XMLSchema#string

Peter J Felock

http://www.w3.org/2001/XMLSchema#string

Philip M McKenna

http://www.w3.org/2001/XMLSchema#string

Renee C Hrin

http://www.w3.org/2001/XMLSchema#string

P2860

Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration

Design and synthesis of conformationally constrained inhibitors of non-nucleoside reverse transcriptase

Complexes of HIV-1 reverse transcriptase with inhibitors of the HEPT series reveal conformational changes relevant to the design of potent non-nucleoside inhibitors

New targets for inhibitors of HIV-1 replication

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

Improving non-nucleoside reverse transcriptase inhibitors for first-line treatment of HIV infection: the development pipeline and recent clinical data.

HIV-1 reverse transcription: a brief overview focused on structure-function relationships among molecules involved in initiation of the reaction.

Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy.

Mutants of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase resistant to nonnucleoside reverse transcriptase inhibitors demonstrate altered rates of RNase H cleavage that correlate with HIV-1 replication fitness in cell culture.

A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1

P304

3324-3335

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00102-12

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Vandna Munshi

P577

2012-03-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22391531

http://www.w3.org/2001/XMLSchema#string

P932

3370804

http://www.w3.org/2001/XMLSchema#string